Massivemarkets

Nasdaq: LMRI · Listed Dec 11, 2025

Lumexa Imaging Holdings IPO

IPO price

$18.50

Lumexa Imaging Holdings (LMRI) priced its IPO at $18.50 a share and has traded on Nasdaq since Dec 11, 2025.

LMRI today$14.10-23.78%since IPO15-min delayed · as of 5:42:14 AM EST on Nov 19, 2026

See the LMRI quote

First trading day · Dec 11, 2025

IPO price 18.50VWAP 18.62first trade 18.65+0.81% from the IPO pricefell below the IPO price · 3:15high 18.86low 18.26$18.50volume · rising bars above the line, falling bars below409.95K12:554:00
IPO price
$18.50
inside the range of $17 to $20
First trade
$18.65
+0.81% from the IPO price
First-day last trade
$18.50
+0.00% from the IPO price, regular session
Raise
$462.5M
before the underwriters' option

These numbers are from the first trading day, Dec 11, 2025.

How LMRI did against the market

LMRI against the market, from its first trade at 12:55 ET to the last trade of the session.

LMRI from its first trade
-0.80%
Against the market (QQQ)
-1.2 pts

LMRI fell 0.8% from its first trade to the last trade of the session. That is 1.2 points worse than the market.

Same-day moves do not show that LMRI caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

LMRI against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%LMRI -24.11%

The IPO scoreboard

LMRI against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

LMRI against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Lumexa Imaging Holdings '25$462.5M+0.81%+0.00%-7.62%-24.11%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Lumexa Imaging Holdings IPO offers 25M shares to raise $462.5M, before any underwriters' option.

$14$17$18.50$20$23
Expected price range
$17 to $20
IPO price
$18.50
Shares offered
25M
Money raised
$462.5M
Listing date
Dec 11, 2025
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Lumexa Imaging Holdings$462.5M

Where LMRI ranks

Lumexa Imaging Holdings's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • LMRI$1.35B

LMRI news

The latest news and headlines about Lumexa Imaging Holdings (LMRI).

Filings and the company

What Lumexa Imaging Holdings has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Lumexa Imaging Holdings discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 10, 2026

    On November 10, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing the Company's financial results for the quarter ended September 30, 2026.

  • Credit facilityJun 30, 2026

    The Amended Credit Agreement provides for (i) a secured term loan facility of approximately $823 million (the 'Replacement Term Loan') and (ii) a secured revolving line of credit of $250 million (the 'Amended Revolving Credit Facility'). The Replacement Term Loan will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50%, and will mature in December 2032. The Amended Revolving Credit Facility will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50% (subject to reduction upon the achievement of certain senior secured net leverage ratios), and will mature in December 2030.

  • Annual meeting resultsJun 12, 2026

    At the Annual Meeting, all three director nominees were elected and the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified. Set forth below are the final voting results for the proposals submitted to a vote of the Company's stockholders at the Annual Meeting.

  • On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.

  • On March 26, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing certain preliminary financial information for the quarter and year ended December 31, 2025. The preliminary financial information set forth in the press release for the quarter and year ended December 31, 2025 reflects preliminary, unaudited estimates with respect to such results based solely on currently available information, which is subject to change.

About Lumexa Imaging Holdings

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

Ticker
LMRI
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
SERVICES-MEDICAL LABORATORIES
Employees
4.34K
Listed
Dec 11, 2025
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Lumexa Imaging Holdings IPO price?

$18.50 a share.

When did Lumexa Imaging Holdings go public?

Lumexa Imaging Holdings listed on Nasdaq on Dec 11, 2025 under the ticker LMRI.

How much did the Lumexa Imaging Holdings IPO raise?

$462.5M, before any underwriters' option.

How did Lumexa Imaging Holdings open on its first day?

LMRI first traded at $18.65, +0.81% from the IPO price of $18.50.

How did LMRI close on its first day?

Its last regular-session trade was $18.50, +0.00% from the IPO price of $18.50.

What was the LMRI first-day trading range?

$18.03 to $19.25 in the regular session.

How many LMRI shares traded on the first day?

6.52M shares in the regular session.

How many shares did Lumexa Imaging Holdings sell in its IPO?

25M shares.

How did LMRI do against the market on its first day?

LMRI fell 0.8% from its first trade to the last trade of the session. That is 1.2 points worse than the market (QQQ, the Nasdaq-100 ETF).

What exchange is LMRI listed on?

Lumexa Imaging Holdings lists on Nasdaq under the ticker LMRI.

Build with Massive

Get the LMRI data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/LMRI/range/5/minute
Market cap/v3/reference/tickers/LMRI
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.